David P. Hochman - Jan 5, 2022 Form 4 Insider Report for Motus GI Holdings, Inc. (MOTS)

Role: Director, Chairman of the Board
Signature: /s/ Andrew Taylor, power of attorney
Stock symbol: MOTS
Transactions as of: Jan 5, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/7/2022, 03:45 PM
Next filing: Feb 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MOTS	Common Stock, par value $0.0001 per share	Award	$0	+127K	+77.21%	$0.00	292K	Jan 5, 2022	Direct	F1
holding	MOTS	Common Stock, par value $0.0001 per share						2.05M	Jan 5, 2022	By Orchestra BioMed, Inc.	F2
holding	MOTS	Common Stock, par value $0.0001 per share						110K	Jan 5, 2022	By DPH 2008 Trust
holding	MOTS	Common Stock, par value $0.0001 per share						16.6K	Jan 5, 2022	By NSH 2008 Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 5, 2022, Reporting Person was granted 127,083 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").
F2	Reporting Person is a member of the board of directors of Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person jointly exercises dispositive and voting power over the shares owned by OBIO. Reporting Person disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes.

Content

On January 5, 2022, Reporting Person was granted 127,083 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

Reporting Person is a member of the board of directors of Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person jointly exercises dispositive and voting power over the shares owned by OBIO. Reporting Person disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes.